| Value | ₹0.04 Cr |
|---|
NSE filing, NSE: CYIENTDLM. Summary written from the filing by ALFA Finder's alert engine.
Cyient DLM Ltd: key numbers
- Share price
- ₹750.20
- Market cap
- ₹5,955 Cr
- Revenue (annual)
- ₹1,261 Cr
- Net profit (annual)
- ₹73.28 Cr
- P/E (TTM)
- 70.9×Sector 45.0×
- Promoter holding
- 52.11%+0.00% QoQ
- FII holding
- 2.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cyient DLM Ltd
All →Cyient DLM Management Change
Cyient DLM Limited has appointed Mr. Sandip Mishra as Senior Vice President & Chief Human Resources Officer. He joins with over 29 years of global experience in HR leadership.
Cyient DLM Employee Stock Options
Cyient DLM Limited has granted 10,000 stock units under its RSU Scheme 2023. Additionally, 2,63,400 options were granted under the ASOP Scheme 2023 to company associates.
Cyient DLM Earnings Call Transcript: Key Takeaways
Cyient DLM delivered strong 26.5% YoY revenue growth, but EBITDA margins contracted to 8.7% due to aggressive front-ended investments in sales and product development.
Cyient DLM Board Meeting Outcome
Cyient DLM Limited announced the reconstitution of its Corporate Social Responsibility (CSR) committee, effective 15 October 2026. The committee members were updated accordingly.
Cyient DLM Other Announcement
Cyient DLM Ltd has submitted its quarterly shareholding pattern as per Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Cyient DLM Board Meeting Date
Cyient DLM Limited has scheduled a board meeting for October 15, 2026. The board will consider and approve unaudited financial results for the September 2026 quarter.
Other legal & regulatory announcements
All →SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals disclosed that the CIT(Appeals) dismissed its appeal against a ₹7.19 Crore income tax assessment for AY 2018-19. The company is reviewing the order and expects no material impact.
- Value
- ₹7.19 Cr
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals received an Income Tax appellate order allowing its appeal for AY 2023-24. The outstanding tax demand of Rs.45.63 Crore, including interest, stands vacated.
- Value
- ₹45.63 Cr
DPSC Legal & Regulatory
DPSC (India Power Corporation) received NSE and MSE fines for the late FY2026 Annual Report. Total impact is Rs.2.42 lakh; the company plans to seek waiver.
- Value
- ₹0.02 Cr
GSB Finance Legal & Regulatory
Coffers Finvest (formerly GSB Finance) reported SAT disposed of an appeal against one BSE fine, which was withdrawn. The remaining ₹1.20 Lakh fine was paid, leaving no outstanding fines.
- Value
- ₹0.01 Cr
PC Jeweller Legal & Regulatory
SEBI issued administrative warning letters to PC Jeweller's promoter MD and Company Secretary. The warnings concern failure to maintain a structured digital database for a quarterly business update.
Aditya Infotech Legal & Regulatory
Aditya Infotech says ICC arbitration brought by Avathon and SparkCognition was withdrawn after mutual discussions. The company states no material adverse impact on its operations or finances.